Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1Classical hematology 1CNS 1

Conditions

Thrombocytopenia 1Rhabdomyosarcoma 1Osteosarcoma 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Liver Neoplasms 1Jacobs syndrome 1

Interventions

Cyclophosphamide 3fludarabine 2Vorinostat 2Sirolimus 2Mesna 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Busulfan 2sodium thiosulfate 1ripretinib 1repotrectinib 1pralsetinib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1lutetium Lu 177 dotatate 1fludarabine phosphate 1etoposide phosphate 1copper dotatate CU-64 1Ursodeoxycholic Acid 1Topotecan 1Thrombopoietin 1Thiotepa 1Therapeutics 1Sunitinib 1Stem Cell Transplantation 1Simvastatin 1Radiotherapy, Image-Guided 1Radiation 1Psychiatric Rehabilitation 1Plicamycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Germ Cell and Embryonal × Thrombopoietin × Gastrointestinal × Clear all
NCT00187109 2008-04-10

Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy

St. Jude Children's Research Hospital

Phase 1/2 Completed
40 enrolled
CNSClassical hematologyGastrointestinalSarcoma

Jacobs syndrome, Liver Neoplasms, Neoplasms, Germ Cell and Embryonal, Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡